CSRxP launches new website to help lawmakers address drug pricing crisis

As Congress prioritizes action to lower drug prices, the Campaign for Sustainable Rx Pricing yesterday announced a to help lawmakers and their staff better understand the crisis and bipartisan, market-based solutions. 鈥淟owering prescription drug prices was a focal point on the campaign trail in 2018,鈥 CSRxP Executive Director Lauren Aronson. 鈥淣ow it鈥檚 time for members of Congress to turn their campaign promises into substantive action. Our new website will help equip lawmakers with the tools and resources they need to enact real results that protect patients and hold Big Pharma accountable.鈥 AHA is a founding member of CSRxP.
Related News Articles
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription鈥
Headline
The Department of Commerce yesterday released notices announcing national security investigations on imports of pharmaceuticals, pharmaceutical ingredients and鈥
Headline
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. Court of Appeals for the 4th Circuit, urging the court to affirm a decision by the U.S. District鈥
Headline
Sens. Dick Durbin, D-Ill., and Chuck Grassley, R-Iowa, Jan. 23 introduced the Drug-price Transparency for Consumers Act, legislation supported by the AHA that鈥
Headline
The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price negotiations. Negotiations will鈥
Headline
Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, according to a report released Jan. 9 by鈥